US L-carnosine market is estimated to grow at a CAGR of around 6.0% during the forecast period. The factors that contribute to the market growth include a significant prevalence of Autistic Spectrum Disorders (ASD) and chronic diseases, such as diabetes and CVD. In a…

North America L-carnosine market is estimated to grow at a CAGR of over 5.7% during the forecast period. Increasing incidence and prevalence of CVD, neurological disorders, and diabetes are some of the major factors contributing to the growth of the market. CVD is th…

India L-carnosine market is estimated to grow at a CAGR of over 5% during the forecast period. The rising aging population is one of the major factors driving the market growth. As per the World Bank, in 2018, there were more than 83 million of the elderly population…

Europe L-carnosine market is estimated to grow at a CAGR of around 4.3% during the forecast period.   The market is driven by increasing diabetes, eye disorders (cataracts), and kidney-related disorders. There is a growing demand for L-carnosine for the prevention an…

China L-Carnosine Market is estimated to grow at a CAGR of around 6% during the forecast period. China is one of the largest economies across the globe and is known for its significant economic growth, healthcare infrastructure, and technological advancement. Rising …